Skip to main content

Market Overview

Puma Biotechnology (NASDAQ:PBYI) Press Releases

Monday, March 08, 2021

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Mon, 06:15pm)

Friday, March 05, 2021

Polyphor Announces Financial Results for the Full-Year 2020 (Earnings, News, PBYI, Press Releases / Fri, 02:15am)

Thursday, March 04, 2021

Puma Biotechnology to Present at the Barclays Global Healthcare Conference (PBYI, Press Releases / Thu, 05:15pm)

Tuesday, March 02, 2021

Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference (PBYI, Press Releases / Tue, 05:20pm)

Thursday, February 25, 2021

CANbridge Pharmaceuticals and Puma Biotechnology Agree to Terminate NERLYNX® License Agreement and Settle Arbitration (PBYI, Press Releases / Thu, 07:23pm)
Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China (PBYI, Press Releases / Thu, 05:07pm)
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results (PBYI, Press Releases / Thu, 05:05pm)
Puma Biotechnology, Inc. to Host Earnings Call (Earnings, News, PBYI, Press Releases / Thu, 03:30pm)

Thursday, February 11, 2021

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results (PBYI, Press Releases / Thu, 05:15pm)

Tuesday, February 09, 2021

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Tue, 05:15pm)

Friday, January 29, 2021

Puma Biotechnology Presents Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18-Mutated, Metastatic Non-Small Cell Lung Cancer at WCLC 2020 (PBYI, Press Releases / Fri, 09:00am)

Tuesday, January 19, 2021

Puma Biotechnology to Present at the B. Riley Oncology Investor Conference (PBYI, Press Releases / Tue, 10:00am)

Friday, January 15, 2021

Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT "Basket" Trial of Neratinib at ASCO GI (PBYI, Press Releases / Fri, 09:03am)

Thursday, January 14, 2021

ONK Therapeutics Appoints Hugh O'Dowd as Independent Chairman (NTGN, PBYI, Press Releases / Thu, 04:00am)

Tuesday, January 05, 2021

Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference (PBYI, Press Releases / Tue, 05:15pm)

Monday, January 04, 2021

Puma Biotechnology to Present at the H.C. Wainwright VIRTUAL BioConnect Conference (PBYI, Press Releases / Mon, 05:15pm)

Friday, December 11, 2020

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Fri, 06:00pm)
Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the 2020 SABCS (PBYI, Press Releases / Fri, 03:00pm)

Wednesday, December 09, 2020

Wednesday, December 02, 2020

Puma Biotechnology, Inc. Prevails Before European Patent Office Board of Appeals in Decision Upholding European Patent (EP 1848414) as Granted (PBYI, Press Releases / Wed, 09:30am)

Tuesday, November 17, 2020

Puma Biotechnology to Present Neratinib Data at the San Antonio Breast Cancer Symposium (SABCS) (PBYI, Press Releases / Tue, 05:15pm)

Friday, November 06, 2020

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Fri, 05:30pm)

Thursday, November 05, 2020

Puma Biotechnology Announces Interim Results from the Phase II SUMMIT Trial of Neratinib for EGFR Exon 18 Mutated, Metastatic Non-Small Cell Lung Cancer (PBYI, Press Releases / Thu, 05:07pm)
Puma Biotechnology Reports Third Quarter 2020 Financial Results (PBYI, Press Releases / Thu, 05:05pm)
Puma Biotechnology, Inc. to Host Earnings Call (Earnings, News, PBYI, Press Releases / Thu, 03:30pm)

Tuesday, November 03, 2020

Puma Biotechnology to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference (PBYI, Press Releases / Tue, 05:15pm)

Thursday, October 22, 2020

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results (PBYI, Press Releases / Thu, 04:15pm)

Monday, October 05, 2020

Puma Biotechnology Announces Publication of Overall Survival Results from Phase III ExteNET Trial Evaluating Neratinib in HER2-Positive, Hormone Receptor-Positive, Early Stage Breast Cancer (PBYI, Press Releases / Mon, 04:15pm)

Friday, October 02, 2020

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Fri, 05:05pm)

Tuesday, September 08, 2020

Puma Biotechnology to Present at the H.C. Wainwright 22nd Annual Global Investment Conference (PBYI, Press Releases / Tue, 04:15pm)

Thursday, September 03, 2020

Wednesday, August 19, 2020

Puma Biotechnology Announces Publication of Interim Results of Phase II CONTROL Trial in Annals of Oncology (PBYI, Press Releases / Wed, 04:10pm)

Monday, August 10, 2020

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) (PBYI, Press Releases / Mon, 05:15pm)

Thursday, August 06, 2020

Puma Biotechnology Reports Second Quarter 2020 Financial Results (PBYI, Press Releases / Thu, 04:05pm)

1	PLUG, TSLA: Here's Why Alibaba, Plug Power And Tesla Are Moving
2	BTX, PLBY: 28 Stocks Moving in Monday's Pre-Market Session
3	UAL, SNAP: Analysts Upgraded AMC, Snap, United Airlines And Tes...
4	WMT, TSLA: Why Tesla Is Facing Legal Action Threats Fr...
5	QCOM, BABA: Why Is Alibaba Stock Surging Desp...
6	MARA, RIOT: Is Now The Time To Buy...
7	SPWR, TUP: 4 Undervalued...

1	$BTC, NVDA: Two Contrary Bitcoin Tales: How Crypto Mining Equipment Is Buoying Nvi...
2	ESG Factors Are Becoming Important For Hedge Fund Selection
3	Fintech Focus For April 13, 2021
4	AMD, NVDA: AMD Vs. Nvidia: What Do The Charts Say Is A Better Buy Right Now?
5	MTCH, BMBL: 'Trading Nation' Traders Debate Match And...
6	LITE, INTC: Why This Analyst Is Bullish On Lumentum A...
7	WMT, AMZN: Alex Rodriguez, Marc Lore To Buy...